https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43081 Tue 13 Sep 2022 12:19:26 AEST ]]> Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43332 Thu 15 Sep 2022 14:57:43 AEST ]]>